The potential therapeutic effect of guanosine after cortical focal ischemia in rats

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Hansel, Gisele ^a   Ramos, Denise Barbosa ^a   Delgado, Camila Aguilar ^a   Souza, Debora Guerini ^a   Almeida, Roberto Farina ^a   Portela, Luis Valmor ^a   Santos, Andre Quincozes ^a   Souza, Diogo Onofre ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CATALASE; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMATE AMMONIA LIGASE; GLUTATHIONE; GUANOSINE; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VESICULAR GLUTAMATE TRANSPORTER 1; GLUTAMATE TRANSPORTER; NEUROPROTECTIVE AGENT; SLC1A1 PROTEIN, RAT;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FORELIMB; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; THERMOCOAGULATION; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; BRAIN INJURIES; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; ELECTROCOAGULATION; EXPLORATORY BEHAVIOR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ASCORBIC ACID; BLOTTING, WESTERN; BRAIN INJURIES; BRAIN ISCHEMIA; CATALASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCOAGULATION; EXCITATORY AMINO ACID TRANSPORTER 3; EXPLORATORY BEHAVIOR; FORELIMB; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMATE-AMMONIA LIGASE; GLUTATHIONE; GUANOSINE; LIPID PEROXIDATION; MALE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84896282367     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090693     Document Type: Article

References (65)

1. Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79: 1431-1568. (Pubitemid 29473320)
2. Brouns R, De Deyn PP (2009) The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg 111: 483-495.
3. Donnan GA, Fisher M, Macleod M, Davis SM (2008) Stroke. Lancet 371: 1612-1623. (Pubitemid 351626845)
4. Durukan A, Tatlisumak T (2007) Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87: 179-197. (Pubitemid 46860315)
5. Olmez I, Ozyurt H (2012) Reactive oxygen species and ischemic cerebrovascular disease. Neurochem Int 60: 208-212.
6. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. (2013) Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127: e6-e245.
7. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65: 1-105. (Pubitemid 32479155)
8. Had-Aissouni L (2012) Toward a new role for plasma membrane sodiumdependent glutamate transporters of astrocytes: maintenance of antioxidant defenses beyond extracellular glutamate clearance. Amino Acids 42: 181-197.
9. Malarkey EB, Parpura V (2008) Mechanisms of glutamate release from astrocytes. Neurochem Int 52: 142-154. (Pubitemid 350235693)
10. Zadori D, Klivenyi P, Szalardy L, Fulop F, Toldi J, et al. (2012) Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders. J Neurol Sci 322: 187-191.
11. Allen CL, Bayraktutan U (2009) Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 4: 461-470.
12. Elkind MS (2010) Inflammatory mechanisms of stroke. Stroke 41: S3-8.
13. Nanetti L, Raffaelli F, Vignini A, Perozzi C, Silvestrini M, et al. (2011) Oxidative stress in ischaemic stroke. Eur J Clin Invest 41: 1318-1322.
14. Terpolilli NA, Moskowitz MA, Plesnila N (2012) Nitric oxide: considerations for the treatment of ischemic stroke. J Cereb Blood Flow Metab 32: 1332-1346.
15. Tarozzi A, Merlicco A, Morroni F, Bolondi C, Di Iorio P, et al. (2010) Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by Amyloid-beta peptide oligomers. J Biol Regul Homeost Agents 24: 297-306.
16. Tavares RG, Schmidt AP, Tasca CI, Souza DO (2008) Quinolinic acid-induced seizures stimulate glutamate uptake into synaptic vesicles from rat brain: effects prevented by guanine-based purines. Neurochem Res 33: 97-102. (Pubitemid 350242796)
17. Schmidt AP, Bohmer AE, Schallenberger C, Antunes C, Tavares RG, et al. (2010) Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice. Br J Pharmacol 159: 1247-1263.
18. Schmidt AP, Lara DR, Souza DO (2007) Proposal of a guanine-based purinergic system in the mammalian central nervous system. Pharmacol Ther 116: 401-416. (Pubitemid 350116938)
19. Petronilho F, Perico SR, Vuolo F, Mina F, Constantino L, et al. (2012) Protective effects of guanosine against sepsis-induced damage in rat brain and cognitive impairment. Brain Behav Immun 26: 904-910.
20. Pettifer KM, Jiang S, Bau C, Ballerini P, D'Alimonte I, et al. (2007) MPP(+)-induced cytotoxicity in neuroblastoma cells: Antagonism and reversal by guanosine. Purinergic Signal 3: 399-409.
21. Giuliani P, Romano S, Ballerini P, Ciccarelli R, Petragnani N, et al. (2012) Protective activity of guanosine in an in vitro model of Parkinson's disease. Panminerva Med 54: 43-51.
22. Ciccarelli R, Di Iorio P, Giuliani P, D'Alimonte I, Ballerini P, et al. (1999) Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 25: 93-98. (Pubitemid 28554059)
23. Rathbone M, Pilutti L, Caciagli F, Jiang S (2008) Neurotrophic effects of extracellular guanosine. Nucleosides Nucleotides Nucleic Acids 27: 666-672. (Pubitemid 351948576)
24. Uemura Y, Miller JM, Matson WR, Beal MF (1991) Neurochemical analysis of focal ischemia in rats. Stroke 22: 1548-1553.
25. Chang R, Algird A, Bau C, Rathbone MP, Jiang S (2008) Neuroprotective effects of guanosine on stroke models in vitro and in vivo. Neurosci Lett 431: 101-105.
26. Thomazi AP, Boff B, Pires TD, Godinho G, Battu CE, et al. (2008) Profile of glutamate uptake and cellular viability in hippocampal slices exposed to oxygen and glucose deprivation: developmental aspects and protection by guanosine. Brain Res 1188: 233-240. (Pubitemid 350296059)
27. Oleskovicz SP, Martins WC, Leal RB, Tasca CI (2008) Mechanism of guanosine-induced neuroprotection in rat hippocampal slices submitted to oxygen-glucose deprivation. Neurochem Int 52: 411-418.
28. Dal-Cim T, Ludka FK, Martins WC, Reginato C, Parada E, et al. (2013) Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. J Neurochem 126: 437-450.
29. Dal-Cim T, Martins WC, Santos AR, Tasca CI (2011) Guanosine is neuroprotective against oxygen/glucose deprivation in hippocampal slices via large conductance Ca(2)+-activated K+ channels, phosphatidilinositol-3 kinase/ protein kinase B pathway activation and glutamate uptake. Neuroscience 183: 212-220.
30. Moretto MB, Arteni NS, Lavinsky D, Netto CA, Rocha JB, et al. (2005) Hypoxic-ischemic insult decreases glutamate uptake by hippocampal slices from neonatal rats: prevention by guanosine. Exp Neurol 195: 400-406. (Pubitemid 41297791)
31. Moretto MB, Boff B, Lavinsky D, Netto CA, Rocha JB, et al. (2009) Importance of schedule of administration in the therapeutic efficacy of guanosine: early intervention after injury enhances glutamate uptake in model of hypoxiaischemia. J Mol Neurosci 38: 216-219.
32. Connell BJ, Di Iorio P, Sayeed I, Ballerini P, Saleh MC, et al. (2013) Guanosine protects against reperfusion injury in rat brains after ischemic stroke. J Neurosci Res 91: 262-272.
33. Rathbone MP, Saleh TM, Connell BJ, Chang R, Su C, et al. (2011) Systemic administration of guanosine promotes functional and histological improvement following an ischemic stroke in rats. Brain Res 1407: 79-89.
34. Gudkov SV, Gudkova OY, Chernikov AV, Bruskov VI (2009) Protection of mice against X-ray injuries by the post-irradiation administration of guanosine and inosine. Int J Radiat Biol 85: 116-125.
35. Roos DH, Puntel RL, Santos MM, Souza DO, Farina M, et al. (2009) Guanosine and synthetic organoselenium compounds modulate methylmercuryinduced oxidative stress in rat brain cortical slices: involvement of oxidative stress and glutamatergic system. Toxicol In Vitro 23: 302-307.
36. Albrecht P, Henke N, Tien ML, Issberner A, Bouchachia I, et al. (2013) Extracellular cyclic GMP and its derivatives GMP and guanosine protect from oxidative glutamate toxicity. Neurochem Int 62: 610-619.
37. Quincozes-Santos A, Bobermin LD, de Souza DG, Bellaver B, Goncalves CA, et al. (2013) Gliopreventive effects of guanosine against glucose deprivation in vitro. Purinergic Signal.
38. Szele FG, Alexander C, Chesselet MF (1995) Expression of molecules associated with neuronal plasticity in the striatum after aspiration and thermocoagulatory lesions of the cerebral cortex in adult rats. J Neurosci 15: 4429-4448.
39. Paxinos G, Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press.
40. Macrae IM (2011) Preclinical stroke research-advantages and disadvantages of the most common rodent models of focal ischaemia. Br J Pharmacol 164: 1062-1078.
41. Schallert T (2006) Behavioral tests for preclinical intervention assessment. NeuroRx 3: 497-504. (Pubitemid 44443020)
42. de Vasconcelos Dos Santos A, da Costa Reis J, Diaz Paredes B, Moraes L, Jasmin, etal. (2010) Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Res 1306: 149-158.
43. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, et al. (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10: 290-293. (Pubitemid 20096202)
44. Liu S, Zhen G, Meloni BP, Campbell K, Winn HR (2009) Rodent Stroke Model Guidelines for Preclinical Stroke Trials (1st Edition). J Exp Stroke Transl Med 2: 2-27.
45. Biasibetti R, Tramontina AC, Costa AP, Dutra MF, Quincozes-Santos A, et al. (2013) Green tea (2)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia. Behav Brain Res 236: 186-193.
46. Hevel JM, Marletta MA (1994) Nitric-oxide synthase assays. Methods Enzymol 233: 250-258. (Pubitemid 24177548)
47. Vislisel JM, Schafer FQ, Buettner GR (2007) A simple and sensitive assay for ascorbate using a plate reader. Anal Biochem 365: 31-39. (Pubitemid 46617469)
48. Browne RW, Armstrong D (1998) Reduced glutathione and glutathione disulfide. Methods Mol Biol 108: 347-352.
49. Aebi H (1984) Catalase in vitro. Methods Enzymol 105: 121-126.
50. dos Santos AQ, Nardin P, Funchal C, de Almeida LM, Jacques-Silva MC, et al. (2006) Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. Arch Biochem Biophys 453: 161-167. (Pubitemid 44344218)
51. Niizuma K, Yoshioka H, Chen H, Kim GS, Jung JE, et al. (2010) Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim Biophys Acta 1802: 92-99.
52. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695. (Pubitemid 23350687)
53. Crack PJ, Taylor JM (2005) Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 38: 1433-1444. (Pubitemid 40693828)
54. Brown GC (2010) Nitric oxide and neuronal death. Nitric Oxide 23: 153-165.
55. Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, et al. (2011) Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal 14: 1505-1517.
56. Harrison FE, May JM (2009) Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med 46: 719-730.
57. May JM (2012) Vitamin C transport and its role in the central nervous system. Subcell Biochem 56: 85-103.
58. Fujimura M, Tominaga T, Chan PH (2005) Neuroprotective effect of an antioxidant in ischemic brain injury: involvement of neuronal apoptosis. Neurocrit Care 2: 59-66. (Pubitemid 40404630)
59. Warner DS, Sheng H, Batinic-Haberle I (2004) Oxidants, antioxidants and the ischemic brain. J Exp Biol 207: 3221-3231. (Pubitemid 39275296)
60. Sakata Y, Zhuang H, Kwansa H, Koehler RC, Dore S (2010) Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol 224: 325-329.
61. Sanchez-Moreno C, Dashe JF, Scott T, Thaler D, Folstein MF, et al. (2004) Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 35: 163-168. (Pubitemid 38057613)
62. Hertz L (2008) Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacology 55: 289-309.
63. Trotti D, Danbolt NC, Volterra A (1998) Glutamate transporters are oxidantvulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci 19: 328-334. (Pubitemid 28389731)
64. Aoyama K, Watabe M, Nakaki T (2008) Regulation of neuronal glutathione synthesis. J Pharmacol Sci 108: 227-238.
65. Tzingounis AV, Wadiche JI (2007) Glutamate transporters: confining runaway excitation by shaping synaptic transmission. Nat Rev Neurosci 8: 935-947. (Pubitemid 350146934)